Your browser doesn't support javascript.
loading
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Sabatier, Renaud; Garnier, Séverine; Guille, Arnaud; Carbuccia, Nadine; Pakradouni, Jihane; Adelaide, José; Provansal, Magali; Cappiello, Maria; Rousseau, Frédérique; Chaffanet, Max; Birnbaum, Daniel; Mamessier, Emilie; Gonçalves, Anthony; Bertucci, François.
Afiliação
  • Sabatier R; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Garnier S; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Marseille, France.
  • Guille A; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Carbuccia N; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Pakradouni J; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Adelaide J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
  • Provansal M; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Cappiello M; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Marseille, France.
  • Rousseau F; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Marseille, France.
  • Chaffanet M; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Marseille, France.
  • Birnbaum D; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Mamessier E; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Gonçalves A; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
  • Bertucci F; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM-Predictive Oncology Laboratory, Marseille, France.
Front Oncol ; 12: 946257, 2022.
Article em En | MEDLINE | ID: mdl-35965534
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França